Ionis Pharmaceuticals (IONS) Divestments (2016 - 2017)

Ionis Pharmaceuticals (IONS) recorded quarterly Divestments of $2.5 million in Q1 2017, down 43.88% quarter-over-quarter from $4.5 million in Q4 2016.

Ionis Pharmaceuticals (IONS) Divestments (2016 - 2017) Analysis & Trends

Ionis Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $2.5 million for Q1 2017.

  • In Q1 2017, Divestments changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2017 stood at $2.5 million (down 43.88% YoY), while the FY2017 annual figure was $2.5 million, down 43.88% from the prior year.
  • Divestments was $2.5 million for Q1 2017 at Ionis Pharmaceuticals, down from $4.5 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $4.5 million in Q4 2016 to a low of $2.5 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ionis Pharmaceuticals 12.23 Bn 10.31 Bn 243.11 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 2.51 Mn
Dec 31, 2016 4.47 Mn